Owen Hughes

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Emeryville, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Maricel Montano, as attorney-in-fact for Owen Hughes
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Owen Hughes

Form 4 holding Chief Executive Officer, Director

XOMA Royalty Corp

Security class
Performance Stock Units
Shares / value
0
Estimated value
$3,078,580
Report date
14 Jul 2026
Price
$13.89
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

XOMA Royalty Corp

Security class
Depositary Shares - 8.375% B Cumulative Stock
Shares / value
102,000
Estimated value
$2,555,100
Report date
04 Dec 2025
Price
$25.05
Ownership
Direct
Form 4 holding Director

C4 Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
62,000
Estimated value
Report date
24 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Ikena Oncology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
17,520
Estimated value
Report date
07 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ANAPTYSBIO, INC

Security class
Restricted Stock Units
Shares / value
11,250
Estimated value
Report date
11 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

XOMA Royalty Corp

Security class
Depository Shares - 8.375% Series B Cumulative Stock
Shares / value
2,000
Estimated value
Report date
19 Sep 2025
Price
Ownership
Direct
Form 4 holding Director

PARDES BIOSCIENCES, INC.

Security class
Class B Common Stock
Shares / value
0
Estimated value
Report date
23 Dec 2021
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Director

Radius Health, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
15 Aug 2022
Price
$10.00
Ownership
Direct
Form 4 holding Director

Radius Health, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
15 Aug 2022
Price
$4.16
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Translate Bio, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
14 Sep 2021
Price
$38.00
Ownership
Direct
Form 4 holding Director

Translate Bio, Inc.

Security class
Stock Option (righ to buy)
Shares / value
0
Estimated value
Report date
14 Sep 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Translate Bio, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
14 Sep 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

XOMA Royalty Corp

Security class
Depositary Shares - 8.375% Series B Cumulative Stock
Shares / value
0
Estimated value
Report date
14 Jul 2026
Price
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

XOMA Royalty Corp

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
14 Jul 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Owen Hughes

4 XOMA

XOMA Corp

Report period
02 Oct 2023
Transactions
1
Transaction value
+$13,830
Accepted by SEC
04 Oct 2023, 16:30
Role
Exec Chairman and Interim CEO, Director
Next action
Open filing details
4 XOMA

XOMA Corp

Report period
25 Sep 2023
Transactions
2
Transaction value
+$36,075
Accepted by SEC
27 Sep 2023, 16:30
Role
Exec Chairman and Interim CEO, Director
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .